IP Library › Granted Patent US 7,396,535
Granted Patent B2
US 7,396,535 · App. 10/423,778 · Granted Jul 8, 2008

Therapy for obsessive compulsive head banging

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,396,535
App. No.
10/423,778
Granted
Jul 8, 2008
Kind
B2
Abstract

Methods for treating a head banging disorder by local administration of a Clostridial toxin. The local administration can be by intramuscular, transdermal, intradermal or subdermal administration of a low dose of botulinum toxin.

Claims (4)

1. A method for treating an obsessive compulsive head banging disorder, the method comprising the step of administration to a head muscle of a patient with an obsessive compulsive head banging disorder of between about 1 unit and about 1,500 units of a botulinum toxin type A, thereby treating the obsessive compulsive head banging disorder for between about 1 month and about 5 years.

2. The method of claim 1 , wherein administration to head muscle of a patient is by local administration.

3. The method of claim 1 , wherein local administration is by intramuscular injection.

4. The method of claim 1 , wherein treating the obsessive compulsive head banging disorder is for between 4 to 6 months.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE AN ADDITIONAL SERIAL NUMBER NEEDS TO BE ADDED TO THE RECORDATION (CHILD CON APPLICATION) PREVIOUSLY RECORDED ON REEL 014011 FRAME 0961. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT DOCUMENT. Recorded Jan 28, 2008
From: ACKERMAN, ALAN H.
To: ALLERGAN, INC.
Reel/Frame 020426/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2003
From: ACKERMAN, ALAN H.
To: ALLERGAN, INC.
Reel/Frame 014011/0961 →
Continuity (1)
Related Publication 20040213813A1 · Oct 28, 2004